过敏反应介质阻释剂通过稳定肥大细胞膜,从而阻止组胺和其他过敏反应介质(如慢反应物质和缓激肽等)的释放,进而产生抗过敏效果。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
酒石酸异丁嗪 | trimeprazine tartrate | 4330-99-8 | C4H6O6*2C18H22N2S |
|
西那利定 | thenalidine | 86-12-4 | C17H22N2S |
|
西尼二胺 | <i>N</i>,<i>N</i>-dimethyl-<i>N</i>'-[2]pyridyl-<i>N</i>'-[3]thienylmethyl-ethylenediamine | 91-79-2 | C14H19N3S |
|
色甘酸 | cromoglicinic acid | 16110-51-3 | C23H16O11 |
|
氨来诺 | amlexanox | 68302-57-8 | C16H14N2O4 |
|
曲尼司特 | N-(3,4-dimethoxycinnamoyl)anthranilic acid | 53902-12-8 | C18H17NO5 |
|
扎鲁司特 | ZAFIRLUKAST | 107753-78-6 | C31H33N3O6S |
|
异丁司特 | ibudilast | 50847-11-5 | C14H18N2O |
|
富马酸酮替芬 | ketotifen fumarate | 34580-14-8 | C4H4O4*C19H19NOS |
|
噻拉米特 | tiaramide | 32527-55-2 | C15H18ClN3O3S |
|
吡嘧司特钾 | 4H-Pyrido[1,2-a]pyrimidin-4-one, 9-methyl-3-(2H-tetrazol-5-yl)-, potassium salt (1:1) | 100299-08-9 | C10H8KN6O |
|
吡嘧司特 | pemirolast | 69372-19-6 | C10H8N6O |
|
丁夫罗林 | 6-butyl-1,4,7,10-tetrahydro-4,10-dioxo-1,7-phenathroline-2,8-dicarboxylic acid | 54867-56-0 | C18H16N2O6 |
|
2-(2-丙氧苯基)-8-氮杂次黄嘌呤 | zaprinast | 37762-06-4 | C13H13N5O2 |
|
1-苄基-3-甲基咪唑六氟磷酸盐 | 1-Benzyl-3-methylimidazolium hexafluorophosphate | 433337-11-2 | C11H13F6N2P |
|
—— | Trimeprazine Tartrate | 4330-99-8 | C40H50N4O6S2 |
|
—— | 2,3-dihydroxybutanedioic acid;N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine | 4330-99-8 | C40H50N4O6S2 |
|
—— | 2,3-dihydroxybutanedioic acid;hydron;N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine | 1175-88-8 | C4H6O6*2C18H22N2S*2H |
|
—— | Cromolyn disodium salt hydrate | 15826-37-6 | C23H16NaO11 |
|
—— | Pemirolast potassium | 100299-08-9 | C10H7N6O*K |
|
—— | disodium cromoglicate | 15826-37-6 | C23H14O11*2Na |
|